Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.

× No keyword cloud information.

40 in total

1. Risk-benefit decision making for treatment of depression during pregnancy.

Authors: K L Wisner; D A Zarin; E S Holmboe; P S Appelbaum; A J Gelenberg; H L Leonard; E Frank
Journal: Am J Psychiatry Date: 2000-12 Impact factor: 18.112

2. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.

Authors: John Kim; K Wayne Riggs; Shaila Misri; Nancy Kent; Tim F Oberlander; Ruth E Grunau; Colleen Fitzgerald; Dan W Rurak
Journal: Br J Clin Pharmacol Date: 2006-02 Impact factor: 4.335

3. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Authors: Tim F Oberlander; William Warburton; Shaila Misri; Jaafar Aghajanian; Clyde Hertzman
Journal: Arch Gen Psychiatry Date: 2006-08

Review 4. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Authors: Eydie L Moses-Kolko; Debra Bogen; James Perel; Amy Bregar; Kathleen Uhl; Bob Levin; Katherine L Wisner
Journal: JAMA Date: 2005-05-18 Impact factor: 56.272

Review 1. Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.

Authors: Maria Muzik; Susan E Hamilton
Journal: Matern Child Health J Date: 2016-11

1 in total

A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.

1. Risk-benefit decision making for treatment of depression during pregnancy.

2. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.

3. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Review 4. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Review 5. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?

Review 6. SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

7. SSRI treatment during pregnancy: are we asking the right questions?

8. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study.

9. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.

10. An Update on Mood and Anxiety Disorders During Pregnancy and the Postpartum Period.

Review 1. Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.